O. Bender Et Al. , "Discovery of oxindole-based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation," Archiv der Pharmazie , vol.356, no.2, 2023
Bender, O. Et Al. 2023. Discovery of oxindole-based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation. Archiv der Pharmazie , vol.356, no.2 .
Bender, O., Shoman, M. E., Ali, T. F. S., Dogan, R., ÇELİK, İ., Mollica, A., ... Hamed, M. I. A.(2023). Discovery of oxindole-based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation. Archiv der Pharmazie , vol.356, no.2.
Bender, Onur Et Al. "Discovery of oxindole-based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation," Archiv der Pharmazie , vol.356, no.2, 2023
Bender, Onur Et Al. "Discovery of oxindole-based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation." Archiv der Pharmazie , vol.356, no.2, 2023
Bender, O. Et Al. (2023) . "Discovery of oxindole-based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation." Archiv der Pharmazie , vol.356, no.2.
@article{article, author={Onur Bender Et Al. }, title={Discovery of oxindole-based FLT3 inhibitors as a promising therapeutic lead for acute myeloid leukemia carrying the oncogenic ITD mutation}, journal={Archiv der Pharmazie}, year=2023}